Drug-Delivery Technology Market Report 2026

Drug-Delivery Technology Market Overview

• Drug-Delivery Technology market size has reached to $54.24 billion in 2025 • Expected to grow to $91.41 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Increasing Chronic Disease Prevalence Driving Growth Due To Rising Need For Effective Treatment • Market Trend: Innovative Injector Systems Enhancing High-Volume Manufacturing And Multi-Therapy Support • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug-Delivery Technology Market?

Drug-delivery technology refers to the advanced systems and devices designed to deliver pharmaceutical compounds to targeted areas of the body in a controlled and efficient manner. These technologies aim to enhance the therapeutic effects of medications, reduce side effects, and improve patient compliance by utilizing various methods such as oral, injectable, transdermal, and implantable delivery systems. The main types of drug-delivery technology are oral, injectable, topical, ocular, nasal, pulmonary, transmucosal, and implantable. Oral drug delivery involves administering medication via the mouth, typically as tablets or capsules, offering convenience and improved effectiveness through enhanced solubility and absorption technologies. It is used for various applications, including cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, and infections, and is used in hospitals, clinics, diagnostic centers, home care settings, and others.

What Is The Drug-Delivery Technology Market Growth Forecast?

The drug-delivery technology market size is expected to see rapid growth in the next few years. It will grow to $91.41 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to rise of personalized medicine, increasing biologics and biosimilars, demand for long acting drug delivery, technological advances in implantables, growing home care treatment adoption. Major trends in the forecast period include targeted drug delivery systems, controlled and sustained release formulations, patient centric drug delivery devices, minimally invasive delivery technologies, advanced implantable drug systems.

Global Drug-Delivery Technology Market Segmentation

1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable 2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications 3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users Subsegments: 1) By Oral: Tablets, Capsules, Solutions, Suspensions, Powders, Gels 2) By Injectable: Conventional Injection, Self-Injection, Long-Acting Injection 3) By Topical: Creams, Gels, Lotions, Patches, Ointments 4) By Ocular: Eye Drops, Ointments, Gels, Inserts, Implants 5) By Nasal: Sprays, Drops, Powders, Gels 6) By Pulmonary: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers 7) By Transmucosal: Buccal, Sublingual, Rectal, Vaginal 8) By Implantable: Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents

What Is The Driver Of The Drug-Delivery Technology Market?

The increasing prevalence of chronic diseases is expected to propel the growth of the drug-delivery technology market. Chronic diseases refer to long-term medical conditions that typically progress slowly and require ongoing management. The increasing prevalence of chronic diseases is due to a sedentary lifestyle, which reduces physical activity and contributes to obesity and related health issues. Drug-delivery technology enhances chronic diseases by enabling targeted delivery, controlled release, improved bioavailability, and reduced side effects, ultimately improving treatment effectiveness, patient adherence, and disease management. For instance, in July 2024, according to the Australian Burden of Disease Study 2023 by the Australian Institute of Health and Welfare (AIHW), chronic conditions accounted for 91% of non-fatal burden (years lived with disability) and 78% of fatal burden (years of life lost) in 2023. Therefore, the increasing prevalence of chronic diseases is driving the growth of the drug-delivery technology industry.

Key Players In The Global Drug-Delivery Technology Market

Major companies operating in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc.

Global Drug-Delivery Technology Market Trends and Insights

Major companies operating in the drug-delivery technology market are focusing on developing innovative products such as prefilled injection devices to enhance patient convenience, improve dosing accuracy, and ensure safer drug administration. A prefilled injection device is a medical device that comes preloaded with a specific dose of medication, eliminating the need for manual drug filling before administration. For instance, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturing company, launched a new disposable pen injector designed for high-volume manufacturing. The injector features a compact and flexible design with customizable dosing and push-button colors to support multiple therapies, including diabetes, fertility, growth hormones, obesity, and osteoporosis. The device aims to help pharmaceutical companies accelerate market entry by offering a cost-effective, ready-to-use solution while reducing commercialization costs and risks.

What Are Latest Mergers And Acquisitions In The Drug-Delivery Technology Market?

In January 2025, Molex, a U.S.-based provider of electronic interconnect, packaging, and connectivity solutions (via its Phillips Medisize subsidiary, a CDMO for drug delivery), acquired Vectura Group Ltd. for an undisclosed amount. With this acquisition, Molex/Phillips Medisize aims to enhance its drug delivery technology portfolio by integrating Vectura’s proven inhalation formulation and device development capabilities, thereby enabling more comprehensive respiratory and combination therapies. Vectura Group Ltd. is a UK-based company specializing in inhalation drug-device design, formulation development, and combination product manufacturing for dry powder inhalers, metered dose inhalers, nebulizers, and nasal inhalers.

Regional Insights

North America was the largest region in the drug-delivery technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Drug-Delivery Technology Market?

The drug-delivery technology market consists of revenues earned by entities by providing services such as custom drug formulation, controlled-release drug delivery systems, injectable drug delivery solutions, nanosystems for drug delivery, and transdermal drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug-delivery technology market includes sales of microneedle patches, implantable pumps, oral delivery systems, biodegradable drug delivery devices, and liposome-based drug delivery systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Drug-Delivery Technology Market Report 2026?

The drug-delivery technology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the drug-delivery technology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.